Boehringer Ingelheim RCV GmbH & Co KG

Industry / private company


Location: Wien, Austria (AT) AT

ISNI: 0000000405446183

ROR: https://ror.org/026vtvm28

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis (2024) Meder L, Orschel CI, Otto CJ, Koker M, Brägelmann J, Ercanoglu MS, Dähling S, et al. Journal article Learning quantum systems (2023) Gebhart V, Santagati R, Gentile AA, Gauger EM, Craig D, Ares N, Banchi L, et al. Journal article, Review article Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018) Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al. Journal article